SHP Wealth Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
SHP Wealth Management's CYTK Position: Q3 2026 in Review
SHP Wealth Management held its Cytokinetics (CYTK) position steady in Q3 2026 at 20 shares worth $1.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1443.
SHP Wealth Management first reported a position in CYTK in Q1 2026 and has held it in 3 quarters since. 473 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- SHP Wealth Management held 20 shares of Cytokinetics worth $1.7K as of Q3 2026.
- SHP Wealth Management left its Cytokinetics share count unchanged in Q3 2026.
- Cytokinetics made up ﹤0.01% of SHP Wealth Management's portfolio in Q3 2026, its #1443 holding.
- SHP Wealth Management first reported a position in Cytokinetics in Q1 2026 and has held it in 3 quarters since.
- 473 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on SHP Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.